Lv21
180 积分 2025-11-13 加入
Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study
1小时前
已完结
Immune Imbalance and Dynamic Characteristics of T Helper 17, Regulatory T, and Regulatory B Cells in Children With Persistent Immune Thrombocytopenia
2个月前
已完结
[Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021): a guideline interpretation]
2个月前
已完结
Genetic variations in NER pathway gene polymorphisms and Wilms tumor risk: A six‐center case–control study in East China
2个月前
已完结
Fratricide-resistant CD7-CAR T cells in T-ALL
4个月前
已完结
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
4个月前
已完结
Olverembatinib Treatment in Pediatric Patients With Relapsed Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia
4个月前
已完结
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
